drugset / Trial / NCT02259920

Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers

NCT02259920 ↗

Phase 1 Completed 13 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

Study to determine and compare the absorption of KUC 7483 CL from different regions of the GI tract with the immediate release formulation and to compare the absorption of particulate versus solution formulations from the ascending colon

Timeline

Start
2003-12
Primary completion
2004-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator KUC 7483 CL Unknown 80 mg —

Indications

No indication recorded.